⌘K

Login Start Free

Home/Filings/4/0001209191-20-009267

4//SEC Filing

Salzman Amber 4

Accession 0001209191-20-009267

CIK 0001662524other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:47 PM ET

Size

5.3 KB

Accession

0001209191-20-009267

Insider Transaction Report

Form 4

Period: 2020-02-12

AKCEA THERAPEUTICS, INC.AKCA

Director

Transactions

Award
Stock Option (right to buy)
2020-02-12+53,000→ 53,000 total
Exercise: $17.94Exp: 2030-02-11→ Common Stock (53,000 underlying)

Footnotes (1)

[F1]The shares vest over a four year period in equal annual installments beginning on February 12, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AKCEA THERAPEUTICS, INC.

CIK 0001662524

Entity typeother

Related Parties

1

filerCIK 0001674536

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 4:47 PM ET
Size: 5.3 KB

View on SEC.gov